RxSight, Inc.
RXST· Nasdaq
Released Nov 9, 2023, after the close
10-Q filed Nov 9, 2023, 40 days after period end · 0000950170-23-062099
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $22.20M | $12.62M | $5.79M | $4.17M |
| Net Income | -$12.42M | -$16.82M | -$12.67M | $30.66M |
| EPS Diluted |
RxSight, Inc. · CIK 1111485 · Engraved from SEC EDGAR
| -$0.35 |
| -$0.61 |
| -$0.68 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.